About Redwood Scientific Technologies
Redwood Scientific Technologies is a private company based in Albany, New York. It has reported $5,646,253 raised in three offerings on Form D since February 2015. Its chief executive is Jason Cardiff.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 4, 2023 | Jul 11, 2023 | $1,140,000fully sold | 13 | $87,692 | Equity, OptionsRule 506(b) | Form D ↗ |
| Apr 15, 2015 | May 15, 2015amended Jan 28, 2016 | $3,441,253of $5.0M target | 35 | $98,322 | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 16, 2015 | Feb 19, 2015 | $1,065,000of $1.5M target | 21 | $50,714 | Equity, Debt, OptionsRule 506(b) | Form D ↗ |
| Total, three offerings | $5,646,253 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Redwood Scientific Technologies's Form D filed Jul 11, 2023.
DD
David Duncan
Chief Operating Officer
JH
John Harrington
Chief Financial Officer
BK
Brian Kennedy
Director
JC
Jason Cardiff
Chief Executive Officer and President, director
CH
Christine Hayes
Director
Earlier filings also listed Patrick Moynihan (director, last listed Jan 2016), Kevin Harrington (director, last listed Jan 2016), Jacques Poujade (director, last listed Jan 2016), Jaci Warren (director, last listed Jan 2016) and Eunjung Cardiff (director, last listed Jan 2016).